Biblio

Export 366 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is E  [Clear All Filters]
Journal Article
T. Eichler, Thyrian, J. René, Hertel, J., Richter, S., Wucherer, D., Michalowsky, B., Teipel, S., Kilimann, I., Dreier, A., and Hoffmann, W., “Unmet Needs of Community-Dwelling Primary Care Patients with Dementia in Germany: Prevalence and Correlates.”, J Alzheimers Dis, vol. 51, no. 3, pp. 847-55, 2016.
A. Wallin, Román, G. C., Esiri, M., Kettunen, P., Svensson, J., Paraskevas, G. P., and Kapaki, E., “Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1417-1441, 2018.
Y. Wang, Wang, Y., Bharti, V., Zhou, H., Hoi, V., Tan, H., Wu, Z., Nagakannan, P., Eftekharpour, E., and Wang, J. - F., “Upregulation of Thioredoxin-Interacting Protein in Brain of Amyloid-β Protein Precursor/Presenilin 1 Transgenic Mice and Amyloid-β Treated Neuronal Cells.”, J Alzheimers Dis, vol. 72, no. 1, pp. 139-150, 2019.
M. Asif Emran Emon, Kodamullil, A. Tom, Karki, R., Younesi, E., and Hofmann-Apitius, M., “Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 56, no. 2, pp. 677-686, 2017.
K. R. Thomas, Edmonds, E. C., Eppig, J., Salmon, D. P., and Bondi, M. W., “Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 64, no. 1, pp. 195-204, 2018.
K. R. Thomas, Edmonds, E. C., Eppig, J., Salmon, D. P., and Bondi, M. W., “Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 64, no. 1, pp. 195-204, 2018.
S. André, Ansciaux, E., Saidi, E., Larbanoix, L., Stanicki, D., Nonclercq, D., Elst, L. Vander, Laurent, S., Muller, R. N., and Burtea, C., “Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1547-1565, 2017.
M. Müller, H Kuiperij, B., Versleijen, A. A. M., Chiasserini, D., Farotti, L., Baschieri, F., Parnetti, L., Struyfs, H., De Roeck, N., Luyckx, J., Engelborghs, S., Claassen, J. A., and Verbeek, M. M., “Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1321-33, 2016.
S. Westwood, Baird, A. L., Anand, S. N., Nevado-Holgado, A. J., Kormilitzin, A., Shi, L., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Baker, S., Buckley, N. J., Kate, M. Ten, Scheltens, P., Teunissen, C. E., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Sala, I., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Freund-Levi, Y., Frölich, L., Dobricic, V., Legido-Quigley, C., Bertram, L., Barkhof, F., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, and Lovestone, S., “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
O. Anna Skrobot, McKnight, A. Jayne, Passmore, P. Anthony, Seripa, D., Mecocci, P., Panza, F., Kalaria, R., Wilcock, G., Munafò, M., Erkinjuntti, T., Karhunen, P., Pessi, T., Martiskainen, M., Love, S., and Kehoe, P. Gavin, “A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort.”, J Alzheimers Dis, vol. 53, no. 3, pp. 981-9, 2016.
Y. Kim, Jang, H., Kim, S. Joo, Cho, S. Hyun, Kim, S. Eun, Kim, S. Tae, Kim, H. Jin, Moon, S. Hwan, Ewers, M., Im, K., Kwon, H., Na, D. L., and Seo, S. Won, “Vascular Effects on Depressive Symptoms in Cognitive Impairment.”, J Alzheimers Dis, vol. 65, no. 2, pp. 597-605, 2018.
E. X. Wei, Oh, E. S., Harun, A., Ehrenburg, M., and Agrawal, Y., “Vestibular Loss Predicts Poorer Spatial Cognition in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 995-1003, 2018.
S. A. Chau, Herrmann, N., Sherman, C., Chung, J., Eizenman, M., Kiss, A., and Lanctôt, K. L., “Visual Selective Attention Toward Novel Stimuli Predicts Cognitive Decline in Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1339-1349, 2017.
B. Krause-Sorio, Siddarth, P., Kilpatrick, L., Milillo, M. M., Aguilar-Faustino, Y., Ercoli, L., Narr, K. L., Khalsa, D. S., and Lavretsky, H., “Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 87, no. 2, pp. 569-581, 2022.
H. Borghys, Van Broeck, B., Dhuyvetter, D., Jacobs, T., de Waepenaert, K., Erkens, T., Brooks, M., Thevarkunnel, S., and Araujo, J. A., “Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests.”, J Alzheimers Dis, vol. 56, no. 2, pp. 763-774, 2017.
E. Ebrahimie, Nik, S. Hani Mouss, Newman, M., Van Der Hoek, M., and Lardelli, M., “The Zebrafish Equivalent of Alzheimer's Disease-Associated PRESENILIN Isoform PS2V Regulates Inflammatory and Other Responses to Hypoxic Stress.”, J Alzheimers Dis, vol. 52, no. 2, pp. 581-608, 2016.

Pages